BC Innovations | Oct 25, 2012
Targets & Mechanisms

Myelination from neural stem cells

University of California, San Francisco , Oregon Health & Science University and StemCells Inc. have found that neural stem cell transplants could remyelinate axons and treat myelination disorders including Pelizaeus-Merzbacher disease. 1,2 The biotech is planning...
BC Week In Review | Apr 13, 2009
Clinical News

Biovista preclinical data

In a mouse model of MS, BVA-101 significantly reduced symptoms, the magnitude of which was statistically similar to reductions induced by dexamethasone. BVA-101, which is an undisclosed drug that Biovista is repositioning for MS, showed...
Items per page:
1 - 2 of 2